GLP-1 agonists have been used to treat type 2 diabetes for about two decades and have a long safety record

Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous

Because of epitalons action on melatonin production, nighttime administration is ideal
If a client has a vitamin B12 deficiency, they might benefit from an injection
These monotherapy results established proof of concept that amylin receptor agonism alone can produce clinically meaningful weight reduction and informed the dose selection of 2.4 mg for the combination product CagriSema
The benzyl alcohol present helps inhibit bacterial growth, facilitating multiple withdrawals under aseptic conditions